创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

GE Chuang, HU Jialiang, XU Hanmei. Advances in CD47 Related Signaling Pathways and Its Association with Diseases[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 371-378.
Citation: GE Chuang, HU Jialiang, XU Hanmei. Advances in CD47 Related Signaling Pathways and Its Association with Diseases[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 371-378.

Advances in CD47 Related Signaling Pathways and Its Association with Diseases

  • CD47 is a widely expressed cell surface glycoprotein interacting with a variety of intracellular and extracellular proteins such as thrombospondin 1(TSP1) and signal regulatory protein alpha (SIRPα) and participating in the regulation of multiple signaling pathways, which play an important role in the occurrence and progression of a variety of diseases such as tumor, cardiovascular diseases and autoimmune diseases. This paper illustrates the structure and expression of CD47, its interactions with other proteins, the signaling pathways involving CD47 and its association with diseases in order to provide help for CD47-targeting strategies development.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return